# ZILRETTA™ for Treatment of Idiopathic Adhesive Capsulitis

> **NCT04831255** · PHASE1 · TERMINATED · sponsor: **University of Virginia** · enrollment: 39 (actual)

## Conditions studied

- Adhesive Capsulitis
- Frozen Shoulder
- Adhesive Capsulitis of Shoulder

## Interventions

- **DRUG:** triamcinolone acetonide extended-release injectable suspension

## Key facts

- **NCT ID:** NCT04831255
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-21
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** Not able to find enough subjects
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04831255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04831255, "ZILRETTA™ for Treatment of Idiopathic Adhesive Capsulitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04831255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*